Neuromonics Announces Publication of Private Practice Tinnitus Treatment Study
Published: Nov 11, 2008
BETHLEHEM, Pa.--(BUSINESS WIRE)--Neuromonics, Inc. today announced publication of the largest private practice study evaluating the Neuromonics Tinnitus Treatment, which comprehensively targets the condition’s neurological processes. Tinnitus (ringing in the ears) is a widespread, difficult-to-treat condition affecting 40 to 50 million Americans. Published in the November issue of Annals of Otology, Rhinology & Laryngology, the 470-patient study demonstrates that 92 percent of the patient cohort who met suitability criteria significantly improved following the Neuromonics Tinnitus Treatment.